During the past decade, Hospital Universitario Dr Peset conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 26 clinical trials were completed, i.e. on average, 33.8% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 18 clinical trials were completed. i.e. 47.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Dr Peset" #1 sponsor was "PETHEMA Foundation" with 22 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Bayer" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Dr Peset" #1 collaborator was "Celgene" with 4 trials as a collaborator, "Dynamic Science S.L." with 4 trials as a collaborator, "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 3 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "Pfizer" with 3 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Dr Peset" are "Multiple Myeloma" (15 trials), "Breast Cancer" (5 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Acute Myeloid Leukemia" (3 trials) and "Alzheimer's Disease" (3 trials). Many other conditions were trialed in "Hospital Universitario Dr Peset" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Dr Peset" are "Drug" (102 trials), "Other" (10 trials), "Biological" (6 trials), "Device" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Dexamethasone" (13 trials), "Bortezomib" (6 trials), "Daratumumab" (6 trials) and "Lenalidomide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Dr Peset" are 125 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario Dr Peset". 1 are not yet recruiting, 20 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Hospital Universitario Dr Peset, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Dr Peset, 8 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 5 trials that are defined as “Not Applicable".